西班牙HIV感染者CD4细胞<100/μL时隐球菌感染的多中心队列研究
该多中心队列研究在西班牙纳入576例CD4+ T细胞≤100/μL的HIV感染者,用侧流法检测储存血浆隐球菌抗原,CrAg+总患病率为7.5%,且CrAg+与8周和6个月死亡率升高独立相关。研究者建议更新西班牙指南,对此类患者常规筛查隐球菌感染。
要点
- 西班牙HIV感染者CD4≤100/μL时CrAg+患病率为7.5%。
- CrAg+与8周死亡风险升高独立相关(HR 5.36)。
- 每筛查114例可提前发现1例隐球菌脑膜炎。
核心结论
- 西班牙HIV感染者CD4+ T细胞≤100/μL时CrAg+患病率超过7%,应更新指南推荐常规筛查。
研究设计与样本
- 多中心队列研究,纳入西班牙艾滋病研究网络队列中576例CD4+ T细胞≤100/μL且随访>4周(除非死亡)的HIV感染者,用侧流法检测储存血浆CrAg。
主要发现
- 576例中43例CrAg+,总患病率7.5%,不同出生地间无差异。
- CrAg+与8周死亡率升高独立相关(HR 5.36,95%CI 1.46-19.56)。
- CrAg+与6个月死亡率升高独立相关(HR 3.12,95%CI 1.19-8.21)。
- 43例CrAg+中10例报告隐球菌脑膜炎,CrAg阴性者无隐球菌脑膜炎病例。
- 5例在血浆采集时已患隐球菌脑膜炎,5例在随访期间发生。
关键数值与推荐
- 世界卫生组织推荐对CD4+ T细胞<100/μL的HIV感染者常规筛查隐球菌感染,依据是撒哈拉以南非洲该亚组CrAg+患病率≥3%。
- 西班牙艾滋病研究组指南此前不推荐常规筛查。
临床怎么用
- 对CD4+ T细胞≤100/μL的HIV感染者应考虑常规CrAg筛查,无论其出生地。
- CrAg+患者需警惕隐球菌脑膜炎风险并加强随访管理。
局限性
- 研究仅基于西班牙人群,结论能否推广至其他欧洲人群需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The World Health Organization recommends routinely screening HIV-infected patients with CD4+ T-cell counts <100/μL for cryptococcal infection to prevent cryptococcal meningitis (CM), based on studies in Sub-Saharan Africa where the prevalence of positive cryptococcal antigen (CrAg+) is ≥ 3% in this subgroup. Data about such prevalence in Spain are unavailable and rare in other European countries. Thus, the Spanish AIDS Study Group guidelines do not recommend routinely screening. We aim to determine the prevalence and outcomes of cryptococcal infection in this subgroup of patients in Spain. METHODS: We determined CrAg using a lateral flow assay in banked plasma from participants in the cohort of the Spanish AIDS Research Network. Eligible patients had CD4+ T-cell counts ≤100/μL at the time of plasma collection and a follow-up >4 weeks, unless they died. RESULTS: We included 576 patients from June 2004 to December 2017. Of these, 43 were CrAg+ for an overall prevalence of 7.5%. There were no differences depending on birthplace. The CrAg+ was independently associated with a higher mortality at eight weeks (hazard ratio (HR) 5.36, 95% confidence interval (CI) 1.46-19.56) and 6 months (HR 3.12, 95% CI 1.19-8.21). CM was reported in 10 of the 43 CrAg+ patients. There were no cases among negatives. Five patients had CM when the plasma was collected and five developed it during the follow-up. The number of subjects needed to screen to anticipate the diagnosis of one CM case was 114. CONCLUSIONS: The CrAg+ prevalence among HIV-infected patients with CD4+ T-cell counts ≤100/μL diagnosed in Spain, both immigrants and native-born Spanish, is >7%. Consequently, the Spanish AIDS Study Group guidelines have to be updated and recommend routine screening for cryptococcal infection in these patients. Future studies should explore whether this recommendation could be firmly applied to other European populations.
引用
- Pérez-Jacoiste Asín MA, Bisbal O, Iribarren JA, et al. Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study. Clin Microbiol Infect. 2020. PMID: 33069858. doi:10.1016/j.cmi.2020.09.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。